This New Nasdaq Biotech Profile Has Multiple Mouth-Watering Potential Catalysts To Know Now
Full Report Arrives 9:30AM EST Tomorrow
Sign Up To My SMS Update System - Directions Below
I've been tracking a specific Nasdaq biotech profile closely, and due to several potential catalysts, it could be on the verge of making a vertical move in the near term.
Long term, it could be even better. Here's why...
This company could see major exposure in at least two separate markets.
One market is expected to reach $40Bn+ by 2026 while the other could reach an astounding $1Tn+ by 2027.
Long story short, opportunities galore is what you need to understand when checking out this burgeoning company.
I don't want to tease you too hard so I'll tell you this. At 9:30AM EST tomorrow your full report arrives. Make sure your schedule is cleared.
Here's a few potential catalysts to chew on in the mean time.
New Nasdaq Biotech - 3 Potential Catalysts To Know
#1. Hedge funds. A handful of big name hedge funds have taken notice of this company even though it has a relatively small market cap.
What are they seeing that the normal Joe isn't?
#2. Bullish triggered technicals. As of Tuesday's close, this profile was displaying a slew of triggered technicals across the short, medium, and long term on the Barchart website.
#3. A major data announcement. Recent positive news regarding one of the company's main pipeline potential treatments paints the picture of a future product that could be a true game-changer in its market.
Since you've got some time now, do this to ensure you'll get the report and any updates as quickly as possible: